The Department of Laboratory Medicine and Pathology at the University of Minnesota Medical School is committed to bringing leading-edge basic and applied research and innovation to patient care.

The research-intensive faculty within the department have several major focus areas including cancer, immunology, cardiovascular disease, renal disease, diabetes, and genetics. The faculty consist of tenured associate and full professors, several of which currently hold endowed chairs or professorships. They interface with University of Minnesota departments and centers such as the Center for Immunology, Masonic Cancer Center, and the Institute for Translational Neuroscience.

 

 

 

 

News

New residency program video released

The new residency program video is part of our effort to highlight outstanding opportunities for graduate medical education in pathology at the University of Minnesota.

LMP Residency Program

Bell symposium

41st E.T. Bell fall pathology symposium

Elexius Bell

The 41st E.T. Bell fall pathology symposium, "Lung, thymus and head and neck pathology: Update on classifications, diagnosis, molecular testing and therapy," will be held Friday, October 28, 2016, 8:00 am- 6:30 pm, at the Commons Hotel, 615 Washington Ave SE, Minneapolis, MN 55414.  There will be a reception at 6:30 pm. following the symposium.

The Minnesota Society of Pathologists's seminar "Clinically relevant update on pathologic diagnosis of lung and head and neck disorders" will be held the following day, October 29, 2016, 8:00 am - 3:30 pm, also at the Commons Hotel. 

Register for these events here: www.mnsocietypath.org/registration

For further information, contact Rosemary at rlobeck@mnsocietypath.org or (952) 929-9398.

Research spotlight

Orr appointed Schindler / Allison Ataxia Chair 

Harry Orr

Harry Orr has been named holder of the James Schindler and Bob Allison Ataxia Chair in Translational Research.  The appointment by the University's Bob Allison Ataxia Research Center (BAARC), which supports clinicians and researchers searching for viable treatments for ataxia, is for three years.  

Funding from the chair will support Orr's research in the molecular genetics of ataxia, principally the autosomal dominant form of spinocerebellar ataxia (SCA1), as well as his activities in faculty mentoring and development and Medical School leadership.